DK0821593T3 - Konjugat af et aktivt middel, et protein og eventuelt et for kroppen ikke som fremmed anset nativt protein - Google Patents
Konjugat af et aktivt middel, et protein og eventuelt et for kroppen ikke som fremmed anset nativt proteinInfo
- Publication number
- DK0821593T3 DK0821593T3 DK96909047T DK96909047T DK0821593T3 DK 0821593 T3 DK0821593 T3 DK 0821593T3 DK 96909047 T DK96909047 T DK 96909047T DK 96909047 T DK96909047 T DK 96909047T DK 0821593 T3 DK0821593 T3 DK 0821593T3
- Authority
- DK
- Denmark
- Prior art keywords
- protein
- conjugate
- pct
- optionally
- active agent
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 4
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- 239000013543 active substance Substances 0.000 title abstract 2
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 208000017520 skin disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0056—Peptides, proteins, polyamino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0036—Porphyrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19514087A DE19514087A1 (de) | 1995-04-13 | 1995-04-13 | Konjugat aus einem Wirkstoff, einem Polyether und ggfs. einem nicht als körperfremd angesehenen, nativen Protein |
PCT/DE1996/000653 WO1996032134A2 (de) | 1995-04-13 | 1996-04-12 | Konjugat aus einem wirkstoff, einem polyether und ggf. einem nicht als körperfremd angesehenen, nativen protein |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0821593T3 true DK0821593T3 (da) | 2002-10-28 |
Family
ID=7759678
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96909047T DK0821593T3 (da) | 1995-04-13 | 1996-04-12 | Konjugat af et aktivt middel, et protein og eventuelt et for kroppen ikke som fremmed anset nativt protein |
Country Status (8)
Country | Link |
---|---|
US (1) | US6150327A (da) |
EP (1) | EP0821593B1 (da) |
JP (1) | JP2000514034A (da) |
AT (1) | ATE220922T1 (da) |
DE (2) | DE19514087A1 (da) |
DK (1) | DK0821593T3 (da) |
ES (1) | ES2180750T3 (da) |
WO (1) | WO1996032134A2 (da) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19706490C1 (de) | 1997-02-19 | 1998-09-17 | Deutsches Krebsforsch | Verfahren zur Herstellung von Säureamiden und zur Metallierung von Verbindungen und Verwendung der nach den Verfahren hergestellten Verbindungen |
DE69932733T2 (de) * | 1998-10-16 | 2007-08-16 | The General Hospital Corp., Boston | Photosensitizer-konjugate zur zielrichtung von intrazellulare pathogene |
JP4680351B2 (ja) * | 2000-07-05 | 2011-05-11 | 日本曹達株式会社 | スターポリマー |
EP1383492A4 (en) * | 2001-03-23 | 2008-12-24 | Napro Biotherapeutics Inc | MOLECULAR CONJUGATES FOR USE IN CANCER THERAPY |
EP1837031B1 (en) * | 2002-06-07 | 2009-10-14 | Waratah Pharmaceuticals, Inc. | Compositions and methods for treating diabetes |
US20040229810A1 (en) * | 2002-10-22 | 2004-11-18 | Antonio Cruz | Gastrin compositions and formulations, and methods of use and preparation |
RU2006131046A (ru) * | 2004-01-30 | 2008-03-10 | Уэрейта Фармасьютикалз, Инк. (Ca) | Совместное применение агониста glp-1 и соединений гастрина |
DE102004034008A1 (de) * | 2004-07-14 | 2006-02-09 | Rösner Research GmbH & Co.KG | Verfahren zur Herstellung von Albumin-Corticoid-Konjugaten |
US8092837B2 (en) * | 2007-04-27 | 2012-01-10 | Biomet Manufacturing Corp | Fibrin based glue with functionalized hydrophilic polymer protein binding agent |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
EP0037388B1 (fr) * | 1980-03-31 | 1984-12-12 | Institut International De Pathologie Cellulaire Et Moleculaire | Formes pharmaceutiques, leur préparation et les compositions qui les contiennent |
ES2001710A6 (es) * | 1986-04-08 | 1988-06-01 | Omnichem Sa | Procedimiento de preparar conjugados de vinblastina y sus derivados |
US5162430A (en) * | 1988-11-21 | 1992-11-10 | Collagen Corporation | Collagen-polymer conjugates |
US5475052A (en) * | 1988-11-21 | 1995-12-12 | Collagen Corporation | Collagen-synthetic polymer matrices prepared using a multiple step reaction |
US5565519A (en) * | 1988-11-21 | 1996-10-15 | Collagen Corporation | Clear, chemically modified collagen-synthetic polymer conjugates for ophthalmic applications |
US4902502A (en) * | 1989-01-23 | 1990-02-20 | Cetus Corporation | Preparation of a polymer/interleukin-2 conjugate |
EP0476011A1 (en) * | 1989-06-07 | 1992-03-25 | The University Of British Columbia | Photosensitizing diels-alder porphyrin derivatives |
AU5858690A (en) * | 1989-06-14 | 1991-01-08 | Cetus Corporation | Polymer/antibiotic conjugate |
DK0437563T3 (da) * | 1989-08-07 | 1995-05-29 | Debio Rech Pharma Sa | Bioligiske aktive lægemiddelpolymerderivater |
US5208323A (en) * | 1989-08-10 | 1993-05-04 | Universite Laval | Coupling of an anti-tumor to an antibody using glutaraldehyde preactivated anti-tumor agent |
US5140013A (en) * | 1989-11-28 | 1992-08-18 | Universite Laval | Maleic anhydride derivatives used as conjugation agents of anti-tumor agents on desired carriers |
US5157075A (en) * | 1990-05-02 | 1992-10-20 | Taenaka Mining Co., Ltd. | Modified melanin |
DE4017439C2 (de) * | 1990-05-30 | 1994-06-23 | Deutsches Krebsforsch | Polyethersubstituierte Tumormittel |
DK0485563T3 (da) * | 1990-05-30 | 1995-03-20 | Deutsches Krebsforsch | Polyethersubstituerede antitumormidler |
JP3051145B2 (ja) * | 1990-08-28 | 2000-06-12 | 住友製薬株式会社 | 新規なポリエチレングリコール誘導体修飾ペプチド |
US5595732A (en) * | 1991-03-25 | 1997-01-21 | Hoffmann-La Roche Inc. | Polyethylene-protein conjugates |
FR2675807B1 (fr) * | 1991-04-23 | 1994-07-01 | Medgenix Group Sa | Conjugue de calcitonine et de polyethylene glycol. |
US5169627A (en) * | 1991-10-28 | 1992-12-08 | Mount Sinai School Of Medicine Of The City University Of New York | Oral pharmaceutical composition containing a polyethylene glycol-immunoglobulin G conjugate for reconstitution of secretory immunity and method of reconstituting secretory immunity |
JPH05286868A (ja) * | 1992-04-03 | 1993-11-02 | Kiyoshi Okawa | 制がん剤複合体およびそのスクリーニング法 |
ZA933926B (en) * | 1992-06-17 | 1994-01-03 | Amgen Inc | Polyoxymethylene-oxyethylene copolymers in conjuction with blomolecules |
EP0648239A4 (en) * | 1992-07-02 | 1995-09-27 | Collagen Corp | BIOCOMPATIBLE POLYMERIC CONJUGATES. |
US5382657A (en) * | 1992-08-26 | 1995-01-17 | Hoffmann-La Roche Inc. | Peg-interferon conjugates |
GB9408746D0 (en) * | 1994-05-03 | 1994-06-22 | Scotia Holdings Plc | Tumour locallising photosensitising compounds |
DE4435087A1 (de) * | 1994-09-30 | 1996-04-04 | Deutsches Krebsforsch | Konjugat zur Behandlung von Infektions-, Autoimmun- und Hauterkrankungen |
-
1995
- 1995-04-13 DE DE19514087A patent/DE19514087A1/de not_active Withdrawn
-
1996
- 1996-04-12 JP JP08530650A patent/JP2000514034A/ja not_active Withdrawn
- 1996-04-12 DK DK96909047T patent/DK0821593T3/da active
- 1996-04-12 AT AT96909047T patent/ATE220922T1/de not_active IP Right Cessation
- 1996-04-12 WO PCT/DE1996/000653 patent/WO1996032134A2/de active IP Right Grant
- 1996-04-12 US US08/949,591 patent/US6150327A/en not_active Expired - Fee Related
- 1996-04-12 ES ES96909047T patent/ES2180750T3/es not_active Expired - Lifetime
- 1996-04-12 DE DE59609483T patent/DE59609483D1/de not_active Expired - Fee Related
- 1996-04-12 EP EP96909047A patent/EP0821593B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ATE220922T1 (de) | 2002-08-15 |
EP0821593A2 (de) | 1998-02-04 |
DE59609483D1 (de) | 2002-08-29 |
DE19514087A1 (de) | 1996-10-17 |
ES2180750T3 (es) | 2003-02-16 |
JP2000514034A (ja) | 2000-10-24 |
US6150327A (en) | 2000-11-21 |
EP0821593B1 (de) | 2002-07-24 |
WO1996032134A2 (de) | 1996-10-17 |
WO1996032134A3 (de) | 1996-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69822665D1 (de) | Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14-dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen | |
NO20092874L (no) | Forhindring og behandling av amyloidogen sykdom | |
BR9714363A (pt) | Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas | |
EP0458079A3 (en) | Ultrasonic contrast agent, its preparation and application as diagnostic or therapeutic | |
DE60038252D1 (de) | Menschlicher antikörper gegen gangliosid gd3 für die transplantationskomplementarität bestimmente regionund derivate des antikörpers gegen das gangliosid gd3 | |
UY23909A1 (es) | Procedimiento para la preparacion de 6- derivados sustitutivos del acido micofenolico | |
DE69116380T2 (de) | Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit | |
DK0821593T3 (da) | Konjugat af et aktivt middel, et protein og eventuelt et for kroppen ikke som fremmed anset nativt protein | |
DK0952853T3 (da) | Konjugat omfattende et aktivt middel, et polypeptid og en polyether | |
ATE198990T1 (de) | Konjugat zur behandlung von entzündlichen erkrankungen | |
PT841939E (pt) | Agentes terapeuticos e doencas auto-imunes | |
PT1343472E (pt) | Pulverizacao nasal tixotropica | |
ATE201680T1 (de) | 2,3,4,5-tetrahydro-1h-3-benzazepin säure- additions-salze | |
DK0787135T3 (da) | Vandopløslige derivater af epipodophyllotoxin, fremgangsmåde til fremstilling deraf og anvendelse som et lægemiddel til beh | |
ATE8739T1 (de) | Pharmazeutische zubereitungen. | |
TR199700963T1 (xx) | Kardiyovask�ler hastal�klar�n tedavisi i�in aminotetralin t�revi. | |
DK0820308T3 (da) | Konjugat til behandling af inflammatoriske sygdomme | |
PT869785E (pt) | 4-hidroxicumarina-3-carboxamidas para o tratamento de diabetes mellitus nao insulinodependente | |
TR199500984A2 (tr) | Selegilin'in epileptik hastaliklarin tedavisinde kullanimi. | |
PT817786E (pt) | Acidos tetronicos substituidos uteis para o tratamento do vih e de outros retrovirus | |
BR0303384A (pt) | Citalopram e seus usos no tratamento de pressão sanguìnea elevada | |
SE9500897D0 (sv) | The pharmacological use of certain cystine derivatives | |
UA37377A (uk) | Спосіб отримання мазі для лікування захворювань, які викликані внутрішньоклітинними інфекційними агентами | |
NO20000694L (no) | Fremgangsmåte for fremstilling av kontrastmidler som i utstrakt grad er fri for bivirkninger | |
ATE349532T1 (de) | Zytotoxisches t-zellepitop des papillomavirus l1- proteins und seine verwendung in diagnostik und therapie |